KYMR
Kymera TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
KYMR vs peer average
49/100
KYMR vs. peer average (C vs. C)
Grade spread
A 1 · B 4 · C 2 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
APGE is the first available peer comparator.
Apogee Therapeutics is another development-stage biotech with valuation driven by immunology pipeline milestones, making it a useful sentiment/risk comparator for Phase 2 execution, though mechanism and portfolio depth differ.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KYMR
Kymera Therapeutics
APGE
Apogee Therapeutics
Grade
C
C
Momentum
40
60
Value
41
41
Sentiment
74
56
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs APGE
KYMR / APGE
Grade Position
In line
KYMR vs. peer average (C vs. C)
49/100
Momentum
40
APGEValue
41
KYMRSentiment
74
KYMRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KYMR
APGE is the first peer returned for this comparison set.